Reno Debets

Reno Debets

Company: Pan Cancer T, Erasmus MC Cancer Institute

Job title: Founder & CSO, Professor


Identification and Testing Of Novel Cancer-Restricted Targets and their TCRS to Develop Safe and Effective T-Cell Treatment 12:00 pm

To fully exploit the therapeutic potential of TCR-T cells, we use our platform to: Limit toxicity attributed to recognition of identical or highly similar targets outside cancers Deliver shared intracellular targets that are cancer-selective to treat large cohorts of patients Counteract the immune-suppressive nature of tumor microenvironmentsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.